Erez Vigodman, a board member at Teva Pharmaceutical, could be appointed chief executive of the world's largest generic-drug maker as early as this week.
from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304617404579305033849297324.html?mod=pls_whats_news_us_business_f
via IFTTT
from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304617404579305033849297324.html?mod=pls_whats_news_us_business_f
via IFTTT
No comments:
Post a Comment